BioWorld - Monday, February 9, 2026

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for Oct. 6, 2020

Oct. 6, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4basebio, Acacia, Aim Immunotech, Akari, Argenx, Aro, Applied Biomath, ATCC, Atomwise, Beigene, Bioatla, Bostongene, Chugai, Dermavant, Derm-Biome, Eisai, GT, Hemogenyx, Hepalink, ILC, Imbio, Ionis, Kaleido, Molecular Partners, Moleculin, Mustang, NEC, Ocugen, Oncimmune, Oxford Biomedica, Respirerx, Roche, Sirion, Taysha Gene, Transgene, Xilio.
Read More

In the clinic for Oct. 6, 2020

Oct. 6, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Affimed, Amgen, Axovant, Brickell, Can-Fite, Cerevel, Chromadex, EIP, Gamida, GSK, Index, Immunicum, Kiniksa, Lilly, Miragen, Neurotrope, Neximmune, NMD Pharma, Phasebio, Puma, Santhera, Tarsus, Vir, Zai.
Read More
Coronavirus, question marks
Virtual Medtech Conference

Industry reflects on the future of innovation as COVID-19 continues to have an impact

Oct. 5, 2020
By Liz Hollis
What is the future of med-tech innovation in the wake of COVID-19? That was the question addressed during the Advanced Medical Technology Association’s Virtual Medtech Conference, with members of industry providing some insight. “I think … that this is going to be in many ways a turning point,” changing the way stakeholders look at devices and the evidence supporting them, said Tom O’Brien, of Johnson & Johnson’s (J&J) Ethicon unit.
Read More
Stephen Hahn, FDA commissioner
Virtual Medtech Conference

FDA’s Hahn on COVID-19 vaccine: ‘Trust the career scientists, trust the FDA’

Oct. 5, 2020
By Annette Boyle
In a fireside chat at the Advanced Medical Technology Association (Advamed)-sponsored Virtual Medtech Conference on Oct. 5, U.S. FDA Commissioner Stephen Hahn addressed questions that have been circulating for months about the political pressure that the agency is facing to quickly approve a vaccine for COVID-19 by reiterating that any decisions will be “completely dependent on when data is mature” from phase III trials.
Read More

Regulatory actions for Oct. 5, 2020

Oct. 5, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Becton Dickinson, Chembio, Haemonetics, Histosonics, Pixcell Medical, Quidel.
Read More

Other news to note for Oct. 5, 2020

Oct. 5, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott Laboratories, Dcao Solutions, Gentex, Icecure Medical, Masimo, Premier, Retispec, Senseonics Holdings, Spineology, Terumo, Vaxxas, Xenocor.
Read More
Magnet attracting money
3Q 2020 financings

Biopharma industry smashes financings record with $100B raised

Oct. 5, 2020
By Peter Winter
According to BioWorld, almost $85 billion was raised by public and private biopharma companies globally in the second and third quarters alone, bringing the dollars generated to date to more than $100 billion – a total that smashes the existing record of about $69 billion that was raised in 2015.
Read More